A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease

A systematic review of cytoreductive prostatectomy outcomes and complications in oligometastatic disease

Objective: To analyze outcomes and complications of cytoreductive prostatectomy (CRP) for oligometastatic prostate cancer (PCa) in order to elucidate its role in this space. Methods: We performed a systematic literature search using three databases (Medline, Scopus, and Web of Science). The primary...

Full description

Bibliographic Details
Main Authors:	Andrey Morozov, Leonid Chuvalov, Mark Taratkin, Mikhail Enikeev, Leonid Rapoport, Nirmish Singla, Eric Barret, Elena Poddubskaya, Maria Borodina, Georg Salomon, Juan Gomez Rivas, Dmitry Enikeev
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Asian Journal of Urology
Subjects:	Systematic review Prostate cancer Oligometastatic Bone metastases Cytoreductive prostatectomy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214388222001436

Similar Items

An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
by: Takafumi Yanagisawa, et al.
Published: (2023-02-01)

Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis
by: Doo Yong Chung, et al.
Published: (2023-05-01)

Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer
by: Johannes Linxweiler, et al.
Published: (2022-01-01)

Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report
by: Tony Zibo Zhuang, et al.
Published: (2022-12-01)

Cytoreductive surgery for men with metastatic prostate cancer
by: Nikolas Katelaris, et al.
Published: (2016-09-01)

Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
by: Yilin Cao, et al.
Published: (2021-11-01)

The role of cytoreductive radical prostatectomy and lymph node dissection in bone‐metastatic prostate cancer: A population‐based study
by: Tingshuai Zhai, et al.
Published: (2023-08-01)

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
by: Michael Chaloupka, et al.
Published: (2021-11-01)

Stereotactic Body Radiotherapy for Patients with Lung Oligometastatic Disease: A Five-Year Systematic Review
by: Guillaume Virbel, et al.
Published: (2021-07-01)

Oligometastatic Disease: When Stage IV Breast Cancer Could Be “Cured”
by: Maria Gion, et al.
Published: (2022-10-01)

Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis
by: Yifeng Mao, et al.
Published: (2022-08-01)

Outcome of lung oligometastatic patients treated with stereotactic body irradiation
by: Guillaume Virbel, et al.
Published: (2022-07-01)

Minimally invasive cytoreductive radical prostatectomy, exploring the safety and feasibility of a single-port or multi-port robotic platform
by: Daniel J. Lama, et al.
Published: (2024-03-01)

Imaging of Oligometastatic Disease
by: Naik Vietti Violi, et al.
Published: (2022-03-01)

Oligometastatic cancer
by: Ivica Ratoša, et al.
Published: (2022-11-01)

Progress in Oligometastatic Prostate Cancer: Emerging Imaging Innovations and Therapeutic Approaches
by: Ryo Oka, et al.
Published: (2024-01-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
by: Adriana C. Gamboa, et al.
Published: (2019-10-01)

Comparison of Cytoreductive Surgery and Resection of Isolated Peritoneal Metastases in Patients with Peritoneal Metastases from Colorectal Cancer: A Retrospective Study
by: Shinya Yoshida, et al.
Published: (2023-04-01)

Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review
by: Antonio Sommariva, et al.
Published: (2022-12-01)

A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy
by: Daisuke Mamiya, et al.
Published: (2024-03-01)

Oligometastatic Pancreatic Cancer to the Liver in the Era of Neoadjuvant Chemotherapy: Which Role for Conversion Surgery? A Systematic Review and Meta-Analysis
by: Ottavia De Simoni, et al.
Published: (2020-11-01)

Synchronous liver and peritoneal metastases from colorectal cancer: Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combined with liver resection a feasible option?
by: Sara Di Carlo, et al.
Published: (2022-12-01)

Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review
by: Mina Sarofim, et al.
Published: (2024-04-01)

A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
by: Giulia Marvaso, et al.
Published: (2023-07-01)

Multiparametric MRI in planning of organ-sparing robot-assisted radical prostatectomy for treatment of localized prostate cancer with low and intermediate risk of progression
by: I. A. Rezvikh, et al.
Published: (2021-08-01)

The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Maher Al Khaldi, et al.
Published: (2022-11-01)

Surgical Management of Post-Prostatectomy Incontinence
by: Arthi Satyanarayan, et al.
Published: (2016-04-01)

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
by: Kristin A. Plichta, et al.
Published: (2021-11-01)

Intermediate results of combination therapy in patients with oligometastatic non-small cell lung cancer
by: D. I. Yudin, et al.
Published: (2018-11-01)

Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery
by: Mina Sarofim, et al.
Published: (2024-04-01)

Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
by: Isaac Yi Kim, et al.
Published: (2022-06-01)

Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
by: Thomas Boerner, et al.
Published: (2021-11-01)

Oligometastatic Prostate Cancer—The Middle Child Syndrome
by: Ee Jean Lim, et al.
Published: (2023-11-01)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
by: Thomas Matoska, et al.
Published: (2023-04-01)

Defining Oligometastatic Bladder Cancer: A Systematic Review
by: Aristotelis Bamias, et al.
Published: (2023-09-01)

Radical prostatectomy versus radiotherapy as local therapy for primary tumors in patients with oligometastatic prostate cancer
by: Won Sik Ham, et al.
Published: (2024-03-01)

Proton Radiotherapy for Patients With Oligometastatic Breast Cancer Involving the Sternum
by: Andrew Johnson, BS, et al.
Published: (2021-11-01)

Oligometastatic Breast Cancer: How to Manage It?
by: Vittoria Barberi, et al.
Published: (2021-06-01)

Hyperthermic intraperitoneal chemotherapy following up-front cytoreductive surgery versus cytoreductive surgery alone for isolated synchronous colorectal peritoneal metastases: A retrospective, observational study
by: Xiusen Qin, et al.
Published: (2022-10-01)

Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
by: Pratistha Koirala, et al.
Published: (2020-08-01)